Present views on molecular mechanisms of formation of fetal growth restriction

1. Mifsud W., Sebire N.J. Placental pathology in early‐onset and late‐onset fetal growth restriction. Fetal Diagn. Ther. 2014; 36(2): 117-28. doi: 10.1159/000359969.
2. Kwon E.J., Kim Y.J. What is fetal programming?: a lifetime health is under the control of in utero health. Obstet. Gynecol. Sci. 2017; 60(6): 506-19. doi: 10.5468/ogs.2017.60.6.506
3. Banister C.E., Koestler D.C., Maccani M.A., Padbury J.F., Houseman E.A., Marsit C.J. Infant growth restriction is associated with distinct patterns of DNA methylation in human placentas. Epigenetics. 2011; 6(7): 920-7. doi: 10.4161/epi.6.7.16079.
4. Стрижаков А.Н., Игнатко И.В., Байбулатова Ш.Ш., Богомазова И.М. Антенатальное метаболическое и эндокринное программирование при беременности высокого риска. Акушерство и гинекология. 2016; 10: 39-47. [Strizhakov A.N., Ignatko I.V., Baibulatova Sh.Sh., Bogomazova I.M. Antenatal metabolic and endocrine programming for high-risk pregnancy. Akusherstvo i Ginekologiya/Obstetrics and Gynecology. 2016; (10): 39-47. (in Russian)].
5. Devaskar S.U., Chu A. Intrauterine growth restriction: hungry for an answer. Physiology (Bethesda). 2016; 31(2): 131-46. http://dx.doi.org/10.1152/physiol.00033.2015
6. Ananth C.V., Lavery J.A., Vintzileos A.M., Skupski D.W., Varner M., Saade G. et al. Severe placental abruption: clinical definition and associations with maternal complications. Am. J. Obstet. Gynecol. 2016; 214(2): 272. e1-272. e9. doi: 10.1016/j.ajog.2015.09.069.
7. Huppertz B., Kadyrov M., Kingdom J.C. Apoptosis and its role in the trophoblast. Am. J. Obstet. Gynecol. 2006; 195(1): 29-39. DOI: 10.1371/journal.pone.0064351
8. Sibley C.P. Treating the dysfunctional placenta. J. Endocrinol. 2017; 234(2): R81-97. https://doi.org/10.1186/s12958-019-0494-7
9. Conrad M., Angeli J.P., Vandenabeele P., Stockwell B.R. Regulated necrosis: disease relevance and therapeutic opportunities. Nat. Rev. Drug Discov. 2016; 15(5): 348-66. http://dx.doi.org/10.1038/nrd.2015.6
10. Narayan N., Lee I.H., Borenstein R., Sun J., Wang R., Tong G. et al. The NAD4 dependent deacetylase SIRT2 is required for programmed necrosis. Nature. 2012; 492(7428): 199-204. doi: 10.1038/nature11700.
11. Silke J., Rickard J.A., Gerlic M. The diverse role of RIP kinases in necroptosis and inflammation. Nat. Immunol. 2015; 16(7): 689-97. doi: 10.1038/ni.3206.
12. Chen X., Li W., Ren J., Huang D., He W.T., Song Y. et al. Translocation of mixed lineage kinase domain-like protein to plasma membrane leads to necrotic cell death. Cell Res. 2014; 24(1): 105-21. http://dx.doi.org/10.1038/cr.2013.171
13. Polykratis A., Hermance N., Zelic M., Roderick J., Kim C., Van T.M. et al. Cutting edge: RIPK1 Kinase inactive mice are viable and protected from TNF-induced necroptosis in vivo. J. Immunol. 2014; 193(4): 1539-43. doi: 10.4049/jimmunol.1400590.
14. Hannan N.J., Beard S., Binder N.K., Onda K., Kaitu’u-Lino T.J., Chen Q. et al. Key players of the necroptosis pathway RIPK1 and SIRT2 are altered in placenta from preeclampsia and fetal growth restriction. Placenta. 2017; 51: 1-9. doi: 10.1016/j.placenta.2017.01.002
15. Bahr B., Galan H.L., Arroyo J.A. Decreased expression of phosphorylated placental heatshock protein 27 in human and ovine intrauterine growth restriction (IUGR). Placenta. 2014; 35(6): 404-10. doi: 10.1016/j.placenta.2014.03.001
16. Clerico E.M., Meng W., Pozhidaeva A., Bhasne K., Petridis C., Gierasch L.M. Hsp70 molecular chaperones: multifunctional allosteric holding and unfolding machines. Biochem. J. 2019; 476(11): 1653-77. doi: 10.1042/BCJ20170380.
17. Li W., Zhong X., Zhang L., Wang Y., Wang T. Heat shock protein 70 expression is increased in the liver of neonatal intrauterine growth retardation piglet. Asian-Australas. J. Anim. Sci. 2012; 25(8): 1096-101. https://doi.org/10.1007/s12192-012-0326-6
18. Huang B.P., Lin C.S., Wang C.J., Kao S.H. Upregulation of heat shock protein 70 and the differential protein expression induced by tumor necrosis factor-alpha enhances migration and inhibits apoptosis of hepatocellular carcinoma cell HepG2. Int. J. Med. Sci. 2017; 14(3): 284-93. DOI: 10.7150/ijms.17861
19. Zhong X., Wang T., Zhang X., Li W. Heat shock protein 70 is upregulated in the intestine of intrauterine growth retardation piglets. Cell Stress Chaperones. 2010; 15(3): 335-42. doi: 10.1007/s12192-009-0148-3
20. Varvarigou A.A. Intrauterine growth restriction as a potential risk factor for disease onset in adulthood. J. Pediatr. Endocrinol. Metab. 2010; 23(3): 215-24. DOI: 10.1515/JPEM.2010.23.3.215
21. Dodington D.W., Desai H.R., Woo M. JAK/STAT – emerging players in metabolism. Trends Endocrinol. Metab. 2018; 29(1): 55-65. DOI: 10.1016/j.tem.2017.11.001
22. Tzschoppe A., Struwe E., Rascher W., Dörr H.G., Schild R.L., Goecke T.W. et al. Intrauterine growth restriction (IUGR) is associated with increased leptin synthesis and binding capability in neonates. Clin. Endocrinol. (Oxf.). 2011; 74(4): 459-66. doi: 10.1111/j.1365-2265.2010.03943.x.
23. Mullen M., Gonzalez-Perez R.R. Leptin-induced JAK/STAT signaling and cancer growth. Vaccines (Basel). 2016; 4(3): 26. Article (PDF Available) in Vaccines 4(3):26 · July 2016 with 60 Reads DOI: 10.3390/vaccines4030026
24. Yi Y., Cheng J.C., Klausen C., Leung P.C.K. TGF-β1 inhibits human trophoblast cell invasion by upregulating cyclooxygenase-2. Placenta. 2018; 68: 44-51. doi: 10.1016/j.placenta.2018.06.313.
25. Chauvin S., Yinon Y., Xu J., Ermini L., Sallais J., Tagliaferro A. et al. Aberrant TGFβ signalling contributes to dysregulation of sphingolipid metabolism in intrauterine growth restriction. J. Clin. Endocrinol. Metab. 2015; 100(7): E986-96. doi: 10.1210/jc.2015-1288
26. Vähätalo R., Asikainen T.M., Karikoski R., Kinnula V.L., White C.W., Andersson S.,et al. Expression of transcription factor GATA-6 in alveolar epithelial cells is linked to neonatal lung disease. Neonatology. 2011; 99(3): 231-40. doi: 10.1159/000317827
27. Alcázar M.A., Dinger K., Rother E., Östreicher I., Vohlen C., Plank C. et al. Prevention of early postnatal hyperalimentation protects against activation of transforming growth factor-β/bone morphogenetic protein and interleukin-6 signaling in rat lungs after intrauterine growth restriction. J. Nutr. 2014; 144(12): 1943-51. doi: 10.3945/jn.114.197657
28. Martín-Estal I., de la Garza R. G., Castilla-Cortázar I. Intrauterine growth retardation (IUGR) as a novel condition of insulin-like growth factor-1 (IGF-1)deficiency. Rev. Physiol. Biochem. Pharmacol. 2016; 170: 1-35.DOI: 10.1007/112_2016_1
29. Sferruzzi-Perri A.N., Owens J.A., Pringle K.G., Roberts C.T. The neglected role of insulin-like growth factors in the maternal circulation regulating fetal growth. J. Physiol. 2011; 589(Pt 1): 7-20. doi: 10.1113/jphysiol.2010.198622.
30. Baumann M.U., Schneider H., Malek A., Palta V., Surbek D.V., Sager R. et al. Regulation of human trophoblast GLUT1 glucose transporter by insulin-like growth factor I (IGF-I). PLoS One. 2014; 9(8): e106037. doi: 10.1371/journal.pone.0106037
31. Illingworth R.S., Gruenewald-Schneider U., Webb S., Kerr A.R., James K.D., Turner D.J. et al. Orphan CpG islands identify numerous conserved promoters in the mammalian genome. PLoS Genet. 2010; 6(9): e1001134. doi: 10.1371/journal.pgen.1001134.
32. Jang H.S., Shin W.J., Lee J.E., Do J.T. CpG and Non-CpG methylation in epigenetic gene regulation and brain function. Genes (Basel). 2017; 8(6): 148. doi: 10.3390/genes8060148.
33. Ye J., Wu W., Li Y., Li L. Influences of the gut microbiota on DNA methylation and histone modification. Dig. Dis. Sci. 2017; 62(5): 1155-64. doi: 10.1007/s10620-017-4538-6.
34. Sen P., Shah P.P., Nativio R., Berger S.L. Epigenetic mechanisms of longevity and aging. Cell. 2016; 166(4): 822-39. https://doi.org/10.1186/s13148-017-0365-z
35. O’Brien J., Hayder H., Zayed Y., Peng C. Overview of MicroRNA biogenesis, mechanisms of actions, and circulation. Front. Endocrinol. (Lausanne). 2018; 9: 402. DOI: 10.3389/fendo.2018.00402
36. Rotwein P. Diversification of the insulin-like growth factor 1 gene in mammals. PLoS One. 2017; 12(12): e0189642. DOI: 10.1371/journal.pone.0189642
37. Chia D.J., Varco-Merth B., Rotwein P. Dispersed chromosomal Stat5b-binding elements mediate growth hormone-activated insulin-like growth factor-I gene transcription. J. Biol. Chem. 2010; 285(23): 17636-47. doi: 10.1074/jbc.M110.117697
38. Rotwein P. Mapping the growth hormone–Stat5b–IGF-I transcriptional circuit. Trends Endocrinol. Metab. 2012; 23(4): 186-93. doi: 10.1016/j.tem.2012.01.001.
39. Klammt J., Neumann D., Gevers E.F., Andrew S.F., Schwartz I.D., Rockstroh D. et al. Dominant-negative STAT5B mutations cause growth hormone insensitivity with short stature and mild immune dysregulation. Nat. Commun. 2018; 9(1): 2105. doi: 10.1038/s41467-018-04521-0.
40. Zhou Z., Liu Y.T., Ma L., Gong T., Hu Y.N., Li H.T. et al. Independent manipulation of histone H3 modifications in individual nucleosomes reveals the contributions of sister histones to transcription. Elife. 2017; 6: e30178. https://doi.org/10.1007/s00294-018-0910-0
41. Chantalat S., Depaux A., Héry P., Barral S., Thuret J.Y., Dimitrov S. et al. Histone H3 trimethylation at lysine 36 is associated with constitutive and facultative heterochromatin. Genome Res. 2011; 21(9): 1426-37. doi: 10.1101/gr.118091.110.
42. Fu Q., McKnight R.A., Callaway C.W., Yu X., Lane R.H., Majnik A.V. Intrauterine growth restriction disrupts developmental epigenetics around distal growth hormone response elements on the rat hepatic IGF-1 gene. FASEB J. 2015; 29(4): 1176-84. DOI: 10.1096/fj.14-258442
43. Дегтярева Е.И., Григорян О.Р., Волеводз Н.Н., Андреева Е.Н., Клименченко Н.И., Мельниченко Г.А., Дедов И.И., Сухих Г.Т. Роль импринтинга генов при внутриутробной задержке роста плода. Акушерство и гинекология. 2015; 12: 5-10. [Degtyareva E.I., Grigoryan O.R., Volevodz N.N., Andreeva E.N., Klimenchenko N.I., Melnichenko G.A., Dedov I.I., Sukhikh G.T. Role of gene imprinting in intrauterine growth restriction. Akusherstvo i ginekologiya/Obstetrics and Gynecology. 2015; (12): 5-10. (in Russian)].

Received 20.06.2109

Accepted 21.06.2019